Prostate cancer biomarker testing and monitoring
Core E:Biomarkers Core
This project develops blood and imaging tests to help track prostate cancer and guide care for people with the disease.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sloan-Kettering Inst Can Research NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11173746 on NIH RePORTER |
What this research studies
You may be asked to consent, give blood or tissue samples, and undergo special PET imaging so the team can link tumor biology with clinical outcomes. The Core coordinates patient registration, scheduled specimen collection, and sample tracking under an IRB-approved clinical protocol at MSK. Researchers will analyze molecular and cellular features from liquid biopsies and imaging (FDHT, PSMA, DLL3 PET) to see how cancer changes over time. The aim is to validate biomarker tests that clinicians can use across projects to inform diagnosis and treatment choices.
Who could benefit from this research
Good fit: Adults with prostate cancer who can attend MSK clinics and are willing to provide samples and undergo PET imaging are the ideal participants.
Not a fit: People without prostate cancer, those who cannot travel to New York, or who cannot undergo PET imaging are unlikely to benefit directly.
Why it matters
Potential benefit: If successful, these tests could help doctors detect changes in prostate cancer earlier and choose treatments more precisely.
How similar studies have performed: PSMA PET and some liquid biopsy methods have already shown clinical value in prostate cancer, but formally credentialing multiple imaging and blood biomarkers together is still being established.
Where this research is happening
New York, United States
- Sloan-Kettering Inst Can Research — New York, United States (Active)
Researchers
- Principal investigator: Scher, Howard I — Sloan-Kettering Inst Can Research
- Study coordinator: Scher, Howard I
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.